« Previous  |  Next »

35. First New Class Of HIV Drugs in 10 Years

The fight against HIV/AIDS is costly, contentious and, for drug companies, a calculated risk. This year, five new antiretroviral drugs in different classifications made strong advances, offering hope to patients with drug-resistant strains of the virus. ...

From SUSAN KARLIN, Discover,  27 Dec 2007

Related Topics: Merck & Company, Inc.,  Food and Drug Administration,  Pfizer Inc.,  Gilead Sciences, Inc.

« Previous  |  Next »

Who is This?

Help us add to our database, by linking this writer their entry in Wikipedia or Source Watch, or by suggesting that we remove it from our index.

Suggest an Entry